CTRI/2019/10/021532已完成1 期
A SINGLE CENTER, OPEN-LABEL, RANDOMISED, COMPARATIVE PILOT STUDY TO EVALUATE SAFETY, TOLERABILITY AND EFFICACY OF 3-D SCAFFOLD MATRIX (BONE GRAFT) FOR DENTAL BONE DEFECT
Indian Institute of Technology Bombay0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a)Male and female patients with age group from 18-55 years
- •b)Patients which are up for extraction sockets
- •c)Patient is willing to be followed for 6 months
- •d)Participants tested negative on skin test for hypersensitivity to Carboxymethyl chitin.
排除标准
- •a)Cases of infection and osteomyelitis occurring from trauma, accident, and facial inju-ry.
- •b)Patients suffering from disease like diabetes mellitus, hyperthyroid, systemic diseases.
- •c)Patients suffering from infectious disease and cardiovascular disease.
- •d)Smokers and patients with history of auto-immune diseases, osteoporosis.
- •e)Patients with adverse medical history will be excluded.
- •f)Female patients who are pregnant.
- •g)Participants tested positive on skin test for hypersensitivity to Carboxymethyl chitin.
研究者
相似试验
已完成
3 期
CLINICAL STUDY EVALUATING EFFICACY AND SAFETY OFINTRAMUSCULAR INJECTION OF PARACETAMOL 500MG/ 2ML IN THE MANAGEMENT OF FEVERCTRI/2021/01/030201Troikaa Pharmaceuticals Ltd
已完成
1 期
A SINGLE-CENTER, OPEN-LABEL, RANDOMIZED, SINGLE-DOSE, 3-WAY CROSSOVER STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF BRIVARACETAM INTRAVENOUS FORMULATION GIVEN AS A 2-MINUTE IV BOLUS INJECTION, A 15-MINUTE IV INFUSION, AND AN ORALLY-DOSED TABLET IN HEALTHY MALE JAPANESE SUBJECTSJPRN-jRCT2080223863CB Japan Co., Ltd.24
尚未招募
4 期
A Clinical study to check the whether the Light therapy given along with cancer treatment with radiation (x-ray) prevents mouth sores in Indian Patients with Head and Neck Cancer.CTRI/2024/02/063175Trisamya Healthcare Pvt Ltd
进行中（未招募）
不适用
A MULTICENTER, RANDOMIZED, OPEN LABEL, SINGLE AND MULTIPLE DOSE STUDY OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 DOSE LEVELS OF PANTOPRAZOLE SODIUM ENTERIC-COATED SPHEROID SUSPENSION IN INFANTS AGED 1 THROUGH 11 MONTHS WITH PRESUMED GERD.INFANTS AGED 1 THROUGH 11 MONTHS WITH PRESUMED GERDEUCTR2006-001132-45-DEWyeth Research Division of Wyeth Pharmaceuticals Inc, Clinical Research and Development56
进行中（未招募）
不适用
A MULTICENTER, RANDOMIZED, OPEN LABEL, SINGLE AND MULTIPLE DOSE STUDY OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 DOSE LEVELS OF PANTOPRAZOLE SODIUM ENTERIC-COATED SPHEROID SUSPENSION IN INFANTS AGED 1 THROUGH 11 MONTHS WITH PRESUMED GERD.EUCTR2006-001132-45-BEWyeth Research Division of Wyeth Pharmaceuticals Inc, Clinical Research and Development56